We have seen a lot of businesses go digital in the last year. Researchers believe that artificial intelligence (“AI”) will be useful in various areas, including the health-care sector. Studies have shown that more than 50% of health-care facilities don’t have a strategy on how to carry out analytics and govern data. This is because the sector still lacks a structured database from which data can be read, interpreted and applied to treatments in the future. With the ongoing pandemic, new approaches to predictive analytics, data analysis and health care are needed more than ever.
Why is data analysis important for this particular sector?
Given that doctors are humans and therefore prone to human error, the probability of making a mistake will always exist. Mistakes in the field of health care not only increase hospital costs and insurance but may, in the extreme, lead to the loss of a human life.
Doctors usually depend on data, which makes data analytics important for health care, as this key information can be a decisive factor when prescribing medications and determining a patient’s mode of treatment.
Real-time analysis of medical data allows us to:
- ensure that a patient’s treatment is more personalized, which in turn raises overall satisfaction
- reduce patient wait times by scheduling and measuring the average time of every procedure
- minimize the risk of treatment of worsening or unaddressed conditions, which require a physician’s attention
- Avoid duplications
- Reduce costs on unnecessary medicament
- Search for more affordable alternatives
- Keep and process data in real time, which allows clinicians to make decisions
How does artificial intelligence fit in all of this?
The adoption of AI models in health care has been a major focus globally for a while. Last year, key players in the market such as Bayer and Microsoft revealed their huge AI budget allocation plans for the health-care industry.
This only confirms that the ongoing pandemic technologies are changing health-care systems worldwide, allowing for the development of new approaches to medical treatments among other things. Generally, they will help decrease costs for medical clinics while improving the quality of health care services.
Real-time data analysis provided by artificial intelligence in healthcare also allows for:
- New methods of improved patient-care quality to be defined
- Minimization of the risk of renal failure and blood poisoning
- Planning medical care for population groups and individuals
- Optimization of the management of treatment outcomes and drug costs
In addition to this, data analysis in health care may help track financial performance and improve the quality of clinical services.
The field of data analytics and AI within the health care sector has attracted a number of innovative companies, including RYAH Group Inc. (CSE: RYAH), that are likely to accelerate the rate at which the world transitions to remote health services.
NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://ibn.fm/RYAH
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.biomedwire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.
